Le Lézard
Classified in: Health
Subject: PDT

Dr. Wusterhausen Introduces New ED Therapy near Fort Worth


LIPAN, Texas, June 23, 2017 /PRNewswire/ -- The Resurge Clinic, is proud to announce they have become a certified provider of the GAINSWavetm, a noninvasive medical therapy that uses the science of LI-ESWT to enhance sexual performance and treats Erectile Dysfunction!

A breakthrough new treatment for ED that doesn't require surgery or medication. (PRNewsfoto/GAINSWave)

The GAINSWavetm protocols use high-frequency acoustic waves to improve sexual performance. As men age, the vessels in their penis weaken, contract and fill with micro-plaque. As these tiny vessels become clogged, you have a harder time achieving and maintaining an erection. Also, the penis decreases in sensitivity making it harder to achieve a pleasurable orgasm. The energy of these high-frequency acoustic waves also known as shockwave therapy can cause a biological reaction resulting in the repair of existing blood vessels and the growth of new blood vessels. Better blood flow equates to better sexual function. GAINSWave helps men with erectile dysfunction overcome their difficulties and can help any man perform better sexually.

"There are over 40 clinical studies on the therapy showing significant improvement in the symptoms of erectile dysfunction. GAINSWavetm is ideal for men looking to improve spontaneous erections without the use of drugs like Viagra or Cialis," says Dr. Wusterhausen, of The Resurge Clinic.  "It has proven to be a safe and effective alternative to Viagra and other oral ED medications." Patients receiving GAINSWave therapy have reported improved quality of erections, sensitivity, and overall performance. Additionally, many men reported decreased refractory times between orgasms, more powerful erections, which has yielded in many men seeking this treatment for sexual performance in addition to erectile dysfunction.

The drug- and surgery-free procedure, known as Extracorporeal Shockwave Therapy (ESWT), takes no longer than 20 minutes and enhances men's sex lives using sound waves, which stimulate the formation of new blood vessels and reactivate dormant ones. The result is improved blood flow, which ultimately helps men achieve and maintain more sustainable erections with increased sensitivity. The Resurge Clinic is now treating men with the GAINSWavetm therapy in their offices at 2105 Clear Lake Rd. Weatherford, TX 76087.

Dr. Wusterhausen is a board certified family practitioner and age management medicine specialists. His passion is helping patients achieve their health goals in a non-traditional approach, including Sexual Wellness.

For More Information Contact:
Alexandra Schapiro
Marketing Account Manager
[email protected]
305-918-1886

 

SOURCE GAINSWave


These press releases may also interest you

at 23:38
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

at 23:33
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

at 22:54
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

at 22:03
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: